HLA-G and its KIR ligands in cancer - Another enigma yet to be solved?

Journal of Pathology

Volumn 196, Issue 3, 2002, Pages 252-253

  Dummer, Reinhard ^a   Urosevic, Mirjana ^a   Trojan, Andreas ^b  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b Department of Internal Medicine   (Switzerland)

Author keywords

Breast cancer; HLA G; ILT 2; Killer cell inhibitory receptor

Indexed keywords

CELL RECEPTOR; HLA ANTIGEN; HLA G ANTIGEN; LIGAND;

ALLOGENEIC RESTRICTION; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ANTIGEN RECOGNITION; ARTICLE; BREAST CANCER; CONTROLLED STUDY; HOST; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOSURVEILLANCE; LYMPHOCYTIC INFILTRATION; MACROPHAGE; MOTHER; NATURAL KILLER CELL; PREGNANCY; PRIORITY JOURNAL; T LYMPHOCYTE; TUMOR CELL;

BREAST NEOPLASMS; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HUMANS; KILLER CELLS, NATURAL; RECEPTORS, IMMUNOLOGIC; T-LYMPHOCYTES, CYTOTOXIC; TUMOR ESCAPE;

EID: 0036187614     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/path.1057     Document Type: Article

References (19)

1. HLA class I antigen downregulation in human cancers: T-cell immunotherapy revives an old story
2. NK cell recognition of non-classical HLA class I molecules
3. HLA-G: A tolerance molecule from the major histocompatibility complex
4. Modulation of HLA-G antigen expression by human cytomegalovirus: Specific induction in activated macrophages harboring human cytomegalovirus infection
5. HLA-G protein up-regulation in primary cutaneous lymphomas is associated with IL-10 expression in large cell T-cell lymphomas and indolent B-cell lymphomas
6. HLA-G upregulation in lung cancer associates with high-grade histology, HLA class I loss and IL-10 production
7. Expression analysis of classic and non-classic HLA molecules before interferon alpha-2b treatment of melanoma
8. Heterogeneity of HLA-G gene transcription and protein expression in malignant melanoma biopsies
9. Increased expression of human histocompatibility leukocyte antigen-G in colorectal cancer cells
10. Specific activation of the nonclassical class I histocompatibility HLA-G antigen and expression of the ILT2 inhibitory receptor in human breast cancer
11. HLA-G protein expression is not induced during malignant transformation
12. HLA-G class I gene expression in normal and malignant hematopoietic cells
13. Expression of HLA-G in human mononuclear phagocytes and selective induction by IFN-gamma
14. IL-10 selectively induces HLA-G expression in human trophoblasts and monocytes
15. In vivo expression of natural killer-cell inhibitory receptors by human melanoma-specific cytolytic T lymphocytes
16. Characterization of an antigen that is recognized on a melanoma showing partial HLA loss by CTL expressing an NK inhibitory receptor
17. Killer inhibitory receptor (CD158b) modulates the lytic activity of tumor-specific T lymphocytes infiltrating renal cell carcinomas
18. Tumor cells regulate the lytic activity of tumor-specific cytotoxic T lymphocytes by modulating the inhibitory natural killer receptor function
19. Regulation of KIR expression in human T cells: A safety mechanism that may impair protective T-cell responses